The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Krylova S.G.

Goldberg Research Institute of Pharmacology and Regenerative Medicine

Lopatina K.A.

Goldberg Research Institute of Pharmacology and Regenerative Medicine

Zueva E.P.

Goldberg Research Institute of Pharmacology and Regenerative Medicine

Safonova E.A.

Goldberg Research Institute of Pharmacology and Regenerative Medicine

Rybalkina O.Yu.

Goldberg Research Institute of Pharmacology and Regenerative Medicine

Povetyeva T.N.

Goldberg Research Institute of Pharmacology and Regenerative Medicine

Suslov N.I.

Goldberg Research Institute of Pharmacology and Regenerative Medicine

Kulagina D.A.

Institute of Problems of Chemical-Energetic Technologies

Sysolyatin S.V.

Institute of Problems of Chemical-Energetic Technologies

Zhdanov V.V.

Goldberg Research Institute of Pharmacology and Regenerative Medicine

Hexaazaizowurtzitane derivate as a new analgesic for chronic pain syndrome relief in experimental rheumatoid artritis

Authors:

Krylova S.G., Lopatina K.A., Zueva E.P., Safonova E.A., Rybalkina O.Yu., Povetyeva T.N., Suslov N.I., Kulagina D.A., Sysolyatin S.V., Zhdanov V.V.

More about the authors

Journal: Russian Journal of Pain. 2020;18(3): 5‑10

Views: 1835

Downloaded: 71


To cite this article:

Krylova SG, Lopatina KA, Zueva EP, et al. . Hexaazaizowurtzitane derivate as a new analgesic for chronic pain syndrome relief in experimental rheumatoid artritis. Russian Journal of Pain. 2020;18(3):5‑10. (In Russ.)
https://doi.org/10.17116/pain2020180315

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.